Biogen Inc. (LON:0R1B)
London
· Delayed Price · Currency is GBP · Price in USD 121.67
+1.37 (1.14%)
At close: May 1, 2025
Biogen Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Net Income | - | 1,632 | 1,161 | 3,047 | 1,556 | 4,001 | Upgrade
|
| Depreciation & Amortization | - | 673.2 | 494.8 | 518.4 | 487.7 | 457.2 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | -88.6 | - | -503.7 | - | -92.5 | Upgrade
|
| Asset Writedown & Restructuring Costs | - | 60.2 | - | 119.6 | 647.3 | 284.7 | Upgrade
|
| Loss (Gain) From Sale of Investments | - | 101.4 | 277.1 | -1,240 | 826.8 | -681.8 | Upgrade
|
| Loss (Gain) on Equity Investments | - | - | - | -2.6 | -34.9 | -3.3 | Upgrade
|
| Stock-Based Compensation | - | 291.2 | 264.2 | 254.1 | 238.6 | 198.3 | Upgrade
|
| Other Operating Activities | - | 361.1 | -1.3 | 81.4 | 63.8 | 253.8 | Upgrade
|
| Change in Accounts Receivable | - | 222.3 | 61.3 | -203.4 | 324.8 | 2.8 | Upgrade
|
| Change in Inventory | - | -273.8 | -130.9 | -320.2 | -462.4 | -316.3 | Upgrade
|
| Change in Other Net Operating Assets | - | -182.2 | -280.1 | -224.4 | -238.7 | 193.8 | Upgrade
|
| Operating Cash Flow | - | 2,876 | 1,547 | 1,384 | 3,640 | 4,230 | Upgrade
|
| Operating Cash Flow Growth | - | 85.85% | 11.77% | -61.97% | -13.95% | -40.24% | Upgrade
|
| Capital Expenditures | - | -153.7 | -277 | -240.3 | -258.1 | -424.8 | Upgrade
|
| Sale of Property, Plant & Equipment | - | - | - | 582.6 | - | - | Upgrade
|
| Cash Acquisitions | - | -1,075 | -6,926 | - | - | -141.8 | Upgrade
|
| Divestitures | - | - | - | - | 28.1 | - | Upgrade
|
| Sale (Purchase) of Intangibles | - | -117.5 | -34.4 | -2.9 | -36.8 | -127 | Upgrade
|
| Investment in Securities | - | 551.5 | 3,148 | 1,213 | -309.8 | 111.9 | Upgrade
|
| Other Investing Activities | - | -4.7 | -11.3 | 24.4 | 12.9 | -26.9 | Upgrade
|
| Investing Cash Flow | - | -799.2 | -4,101 | 1,577 | -563.7 | -608.6 | Upgrade
|
| Long-Term Debt Issued | - | - | 997.2 | - | - | 2,967 | Upgrade
|
| Long-Term Debt Repaid | - | -650 | -809.9 | -1,002 | -170 | -1,500 | Upgrade
|
| Net Debt Issued (Repaid) | - | -650 | 187.3 | -1,002 | -170 | 1,467 | Upgrade
|
| Repurchase of Common Stock | - | - | - | -750 | -1,800 | -6,679 | Upgrade
|
| Other Financing Activities | - | -33.5 | -38 | 4.9 | -116.2 | -61 | Upgrade
|
| Financing Cash Flow | - | -683.5 | 149.3 | -1,747 | -2,086 | -5,273 | Upgrade
|
| Foreign Exchange Rate Adjustments | - | -67.7 | 35.1 | -55.7 | -59.8 | 69 | Upgrade
|
| Net Cash Flow | - | 1,325 | -2,369 | 1,158 | 930.2 | -1,583 | Upgrade
|
| Free Cash Flow | - | 2,722 | 1,270 | 1,144 | 3,382 | 3,805 | Upgrade
|
| Free Cash Flow Growth | - | 114.28% | 11.03% | -66.17% | -11.12% | -42.03% | Upgrade
|
| Free Cash Flow Margin | - | 28.13% | 12.91% | 11.24% | 30.80% | 28.30% | Upgrade
|
| Free Cash Flow Per Share | - | 18.66 | 8.72 | 7.84 | 22.61 | 23.59 | Upgrade
|
| Cash Interest Paid | - | 245.4 | 252.2 | 262.5 | 280.8 | 272.7 | Upgrade
|
| Cash Income Tax Paid | - | 355.1 | 740.7 | 932.9 | 247.9 | 906.7 | Upgrade
|
| Levered Free Cash Flow | - | 3,267 | 971.06 | 1,393 | 2,208 | 2,878 | Upgrade
|
| Unlevered Free Cash Flow | - | 3,423 | 1,125 | 1,547 | 2,365 | 3,011 | Upgrade
|
| Change in Net Working Capital | -1,230 | -1,227 | 892.6 | 878.8 | 226 | 6.5 | Upgrade
|
Updated Feb 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.